Mavacamten

mavacamten · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Mavacamten, covering 2021-10-04 to 2026-08-20. Get the full timeline:

Most recent: Clinical Trial Results: A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy [Phase 3]